Clinical Trial Update: Adebrelimab Plus Carboplatin/Paclitaxel Followed by Adebelizumab with or Without Apatinib in the Treatment of Advanced Recurrent/Metastatic Endometrial Cancer (A-CAPE): a Multicenter, Randomized, Controlled, Open-Label Clinical Trial [Phase 2]

View source ↗

Summary

A Phase 2 multicenter randomized open-label trial evaluating adebrelimab plus carboplatin/paclitaxel followed by adebelizumab, with or without apatinib, in adva…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Adebelizumab (Adebelizumab)
• Adebrelimab (adebrelimab)
• Apatinib (apatinib)
• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Recurrent/Metastatic Endometrial Cancer | Phase 2 | Status: NOT_YET_RECRUITING